文献速递脊柱关节炎

探索疑似中轴型脊柱关节炎中的补体生物标志物

Exploring complement biomarkers in suspected axial spondyloarthritis.
PubMed 文献 · RMD Open · 2024-05-15

该横断面队列纳入515例疑似中轴型脊柱关节炎(axSpA)者(151例axSpA、364例慢性下背痛),检测凝集素途径蛋白等补体指标。axSpA患者L-纤维胶凝蛋白、MASP-2和C3dg升高,MASP-3和CL-L1降低,校正C反应蛋白后C3dg和MASP-3仍显著。多因素分析中MASP-3和C3dg与axSpA诊断相关,但联合HLA-B27虽提高特异性却损失敏感性。

要点

  • axSpA患者血清C3dg和MASP-3在矫正CRP后仍与慢性下背痛患者存在显著差异。
  • 多因素logistic回归中MASP-3和C3dg与axSpA诊断独立相关。
  • HLA-B27联合L-纤维胶凝蛋白、MASP-3和C3dg可提高诊断特异性但伴随敏感性下降。

核心结论

  • 校正CRP后,补体活化产物C3dg和MASP-3在axSpA与慢性下背痛患者间存在显著差异。
  • HLA-B27联合L-纤维胶凝蛋白、MASP-3和C3dg虽提高axSpA诊断特异性,但因伴随敏感性下降似不合理。
  • C3dg和MASP-3在多因素logistic回归中与axSpA诊断相关,提示补体可能参与axSpA炎症过程及发病机制。

研究设计与样本

  • 横断面队列研究,样本来自OptiRef队列,共515例疑似axSpA者,包括151例axSpA患者和364例慢性下背痛患者。
  • 采用免疫测定法检测血清凝集素途径蛋白:甘露聚糖结合凝集素、 collectin liver-1(CL-L1)、M-纤维胶凝蛋白、H-纤维胶凝蛋白、L-纤维胶凝蛋白、MBL相关丝氨酸蛋白酶(MASP)-1、-2、-3、MBL相关蛋白(MAp19和MAp44)及补体活化产物C3dg。

主要发现

  • axSpA患者血清L-纤维胶凝蛋白、MASP-2和C3dg水平升高,MASP-3和CL-L1水平降低;校正CRP后C3dg和MASP-3的差异仍显著。
  • 单因素回归分析显示血清CL-L1、MASP-2、MASP-3和C3dg可预测axSpA诊断;多因素logistic回归中MASP-3和C3dg仍显著。
  • 诊断潜力评估显示,HLA-B27联合L-纤维胶凝蛋白、MASP-3和C3dg测量提高axSpA诊断特异性,但伴随敏感性下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate lectin pathway proteins (LPPs) as biomarkers for axial spondyloarthritis (axSpA) in a cross-sectional cohort with a suspicion of axSpA, comprising newly diagnosed axSpA and chronic low back pain (cLBP) individuals. METHODS: Serum samples from 515 participants within the OptiRef cohort, including 151 axSpA patients and 364 cLBP patients, were measured using immunoassays for LPPs (mannan-binding lectin (MBL), collectin liver-1 (CL-L1), M-ficolin, H-ficolin and L-ficolin, MBL-associated serine proteases (MASP)-1, -2 and -3, MBL-associated proteins (MAp19 and MAp44) and the complement activation product C3dg). RESULTS: Serum levels of L-ficolin, MASP-2 and C3dg were elevated in axSpA patients, whereas levels of MASP-3 and CL-L1 were decreased, and this remained significant for C3dg and MASP-3 after adjustment for C reactive protein (CRP). A univariate regression analysis showed serum levels of CL-L1, MASP-2, MASP-3 and C3dg to predict the diagnosis of axSpA, and MASP-3 and C3dg remained significant in a multivariate logistic regression analysis. Assessment of the diagnostic potential showed that a combination of human leukocyte antigen B27 (HLA-B27) and measurements of L-ficolin, MASP-3 and C3dg increased the diagnostic specificity for axSpA, however, with a concomitant loss of sensitivity. CONCLUSIONS: Serum levels of complement activation, that is, C3dg, and MASP-3 differed significantly between axSpA and cLBP patients after adjustment for CRP. Although combining HLA-B27 with measurements of L-ficolin, MASP-3 and C3dg increased the diagnostic specificity for axSpA, this seems unjustified due to the concomitant loss of sensitivity. However, both C3dg and MASP-3 were associated with axSpA diagnosis in multivariate logistic regression, suggesting an involvement of complement in the inflammatory processes and possibly pathogenesis in axSpA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Mistegård CE, Troldborg A, Loft AG, et al. Exploring complement biomarkers in suspected axial spondyloarthritis. RMD Open. 2024. PMID: 38749532. doi:10.1136/rmdopen-2024-004127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。